Literature DB >> 761456

A program package for simulation and parameter estimation in pharmacokinetic systems.

D Z D'Argenio, A Schumitzky.   

Abstract

A set of programs is presented which has been developed for parameter estimation and simulation of models arising from pharmacokinetic applications. The programs can accommodate linear and nonlinear models with multiple inputs and multiple outputs. When the model is defined by differential equations, non-uniform repetitive dosage regimens can be handled. The model may also be entered in integrated form when single dose studies or uniform multiple dose studies are being considered. The programs employ a variable-step, variable-order integration routine to solve the model differential equations, and the Nelder-Mead simplex procedure to determine the parameter values which minimize a weighted least squares criterion. The programs have been written for an interactive time-sharing environment with the experimental data and model equations stored in files for future use.

Mesh:

Substances:

Year:  1979        PMID: 761456     DOI: 10.1016/0010-468x(79)90025-4

Source DB:  PubMed          Journal:  Comput Programs Biomed        ISSN: 0010-468X


  131 in total

1.  Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Note: caution in use of empirical equations for pharmacodynamic indirect response models.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-12

3.  A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine.

Authors:  E Snoeck; P Jacqmin; A Van Peer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

4.  Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males.

Authors:  P F Smith; A Forrest; C H Ballow; D E Martin; L Proulx
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia.

Authors:  Christopher M Rubino; Alan Forrest; Sujata M Bhavnani; Gary Dukart; Angel Cooper; Joan Korth-Bradley; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

6.  Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.

Authors:  S P Duddu; D J Grant
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

7.  Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin.

Authors:  Alison K Meagher; Alan Forrest; Axel Dalhoff; Heino Stass; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  Pharmacokinetic parameters from data relating to the plasma and biliary excretion kinetics of cefmetazole in rats.

Authors:  M J García-Agundez; C Fernández-Lastra; R Jiménez; J González; E L Mariño
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jul-Sep       Impact factor: 2.441

9.  Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.

Authors:  G L Drusano; J Joshi; A Forrest; R Ruxer; H Standiford; J Leslie; J Wade; S Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Effects of storage on the binding of carboplatin to plasma proteins.

Authors:  K Erkmen; M J Egorin; L M Reyno; R Morgan; J H Doroshow
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.